Editorial: Early detection of neurodegenerative disorders using behavioral markers and new technologies: New methods and perspectives.
作者信息
Manera Valeria, Rovini Erika, Wais Peter
机构信息
CoBTeK Lab, Department of Speech Therapy, Université Cote d'Azur, Nice, France.
Department of Industrial Engineering, University of Florence, Florence, Italy.
出版信息
Front Aging Neurosci. 2023 Feb 28;15:1149886. doi: 10.3389/fnagi.2023.1149886. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Early detection of neurodegenerative disorders using behavioral markers and new technologies: New methods and perspectives.社论：利用行为标志物和新技术早期检测神经退行性疾病：新方法与新视角
Front Aging Neurosci. 2023 Feb 28;15:1149886. doi: 10.3389/fnagi.2023.1149886. eCollection 2023.
2
Brain oscillatory patterns in mild cognitive impairment due to Alzheimer's and Parkinson's disease: An exploratory high-density EEG study.阿尔茨海默病和帕金森病所致轻度认知障碍的脑振荡模式：一项探索性高密度 EEG 研究。
Clin Neurophysiol. 2022 Jun;138:1-8. doi: 10.1016/j.clinph.2022.01.136. Epub 2022 Feb 14.
3
Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease.未折叠的 p53 作为轻度认知障碍、阿尔茨海默病和帕金森病氧化应激的标志物。
Curr Alzheimer Res. 2021;18(9):695-700. doi: 10.2174/1567205018666211117101216.
4
Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity.利用语音和人工智能筛查早期阿尔茨海默病及β-淀粉样蛋白阳性情况。
Brain Commun. 2022 Oct 14;4(5):fcac231. doi: 10.1093/braincomms/fcac231. eCollection 2022.
5
Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.帕金森病、阿尔茨海默病性痴呆和血管性痴呆中的认知障碍：画钟试验的作用
Psychogeriatrics. 2018 Mar;18(2):123-131. doi: 10.1111/psyg.12294. Epub 2018 Feb 7.
6
Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer's and Parkinson's Disease Patients.外周血白细胞增多预测认知能力下降而非行为障碍：一项针对阿尔茨海默病和帕金森病患者的全国性研究。
Dement Geriatr Cogn Disord. 2021;50(2):143-152. doi: 10.1159/000516340. Epub 2021 May 31.
7
Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders.个性化医疗和神经退行性疾病早期诊断技术挑战综述。
Int J Mol Sci. 2023 Feb 7;24(4):3321. doi: 10.3390/ijms24043321.
8
Decoding degeneration: the implementation of machine learning for clinical detection of neurodegenerative disorders.解读神经退行性病变：机器学习在神经退行性疾病临床检测中的应用
Neural Regen Res. 2023 Jun;18(6):1235-1242. doi: 10.4103/1673-5374.355982.
10
Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment.帕金森病轻度认知障碍的神经病理学发现。
Mov Disord. 2020 May;35(5):845-850. doi: 10.1002/mds.27991. Epub 2020 Feb 8.
引用本文的文献
1
Modeling functional connectivity with learning and memory in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中建立与学习和记忆相关的功能连接模型。
Front Neuroimaging. 2025 Apr 25;4:1558759. doi: 10.3389/fnimg.2025.1558759. eCollection 2025.
2
Saliva as a Diagnostic Tool for Systemic Diseases-A Narrative Review.唾液作为全身性疾病的诊断工具——一篇叙述性综述。
Medicina (Kaunas). 2025 Jan 30;61(2):243. doi: 10.3390/medicina61020243.
3
Neurodegeneration-related genes influence pharyngeal activity.神经退行性变相关基因影响咽部活动。
MicroPubl Biol. 2024 Mar 13;2024. doi: 10.17912/micropub.biology.000897. eCollection 2024.
4
Delayed primacy recall performance predicts Alzheimer's disease pathology from unimpaired cognitive baseline.延迟的首因记忆表现可从未受损的认知基线预测阿尔茨海默病病理学。
Alzheimers Dement (Amst). 2024 Jan 18;16(1):e12524. doi: 10.1002/dad2.12524. eCollection 2024 Jan-Mar.
5
A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease.词语列表和故事回忆测试对生物标志物确定的阿尔茨海默病的诊断性能比较。
J Clin Exp Neuropsychol. 2023 Oct;45(8):763-769. doi: 10.1080/13803395.2023.2240060. Epub 2023 Aug 12.
本文引用的文献
1
Multidomain interventions for risk reduction and prevention of cognitive decline and dementia: current developments.多领域干预措施降低和预防认知能力下降和痴呆风险的最新进展
Curr Opin Psychiatry. 2022 Jul 1;35(4):285-292. doi: 10.1097/YCO.0000000000000792. Epub 2022 Jun 9.
2
Multidomain lifestyle interventions for cognition and the risk of dementia: A systematic review and meta-analysis.针对认知和痴呆风险的多领域生活方式干预：一项系统评价与荟萃分析。
Int J Nurs Stud. 2022 Jun;130:104236. doi: 10.1016/j.ijnurstu.2022.104236. Epub 2022 Mar 17.
3
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6.多领域干预：实施精准痴呆风险降低方案的最新技术和未来方向。脑健康服务用户手册-第 6 部分的第 4 部分。
Alzheimers Res Ther. 2021 Oct 11;13(1):171. doi: 10.1186/s13195-021-00875-8.
4
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.阿尔茨海默病的临床诊断：国际工作组的建议。
Lancet Neurol. 2021 Jun;20(6):484-496. doi: 10.1016/S1474-4422(21)00066-1. Epub 2021 Apr 29.
5
Seven Solutions for Neuroprotection in Parkinson's Disease.帕金森病的神经保护七大策略
Mov Disord. 2021 Feb;36(2):306-316. doi: 10.1002/mds.28379. Epub 2020 Nov 13.
6
CSF and blood biomarkers for Parkinson's disease.脑脊液和血液生物标志物用于帕金森病的诊断。
Lancet Neurol. 2019 Jun;18(6):573-586. doi: 10.1016/S1474-4422(19)30024-9. Epub 2019 Apr 10.
7
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease.生活方式干预预防认知障碍、痴呆和阿尔茨海默病。
Nat Rev Neurol. 2018 Nov;14(11):653-666. doi: 10.1038/s41582-018-0070-3.
8
Combining olfactory test and motion analysis sensors in Parkinson's disease preclinical diagnosis: a pilot study.将嗅觉测试和运动分析传感器相结合用于帕金森病临床前诊断的初步研究。
Acta Neurol Scand. 2018 Feb;137(2):204-211. doi: 10.1111/ane.12862. Epub 2017 Oct 29.
9
Editorial: ICT for Assessment and Rehabilitation in Alzheimer's Disease and Related Disorders.社论：用于阿尔茨海默病及相关疾病评估与康复的信息通信技术
Front Aging Neurosci. 2016 Jan 20;8:6. doi: 10.3389/fnagi.2016.00006. eCollection 2016.
10
Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.脑脊液生物标志物能否预测帕金森病患者认知功能障碍的进展？一项系统评价。
Neuropsychol Rev. 2015 Dec;25(4):411-23. doi: 10.1007/s11065-015-9307-8. Epub 2015 Dec 1.
Zotero 插件